We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The assay will help meet the increasing demand for tuberculosis detection, particularly in larger reference laboratories and hospitals, the companies said. Read More
The test “has the potential to become the new first-step screening test” for people who choose not to participate in the existing screening programs for colorectal cancer, the company said. Read More
The company received a $10 million development contract from the Biomedical Advanced Research and Development Authority to develop the dressings. Read More
Outset Medical now plans to source the cartridges through a manufacturing partner in Mexico, which will avoid the expense of air freight from overseas and help mitigate future supply-chain risks, the company said. Read More